This bill limits how much health insurance premiums for Maine state employees can increase, specifically for fiscal years after June 30, 2026. Under the new rules, annual premium increases for active and retired state employees cannot exceed the Consumer Price Index plus 10%, while the Medicare Advantage prescription drug plan is excluded from this cap. The legislation also maintains earlier restrictions on premium increases for years prior to 2026, including a 1.5 percentage point limit for 2014 and 2015 and a 2010-11 funding level cap for 2012 and 2013. These changes directly affect state employees and retirees who currently receive health insurance through the state system.
This bill expands vaccine access in Maine by allowing licensed pharmacists to prescribe, dispense, and administer FDA-approved vaccines without requiring a doctor's prescription for eligible patients. It requires health insurance plans and the MaineCare program to cover all vaccines without deductibles, copayments, or other out-of-pocket costs, including coverage for off-label vaccine use. Pharmacists can administer influenza vaccines to people aged 3 and older, and other CDC-recommended vaccines to adults 18 and older, with additional authority for COVID-19 vaccines to those aged 3 and older. The legislation also clarifies legal definitions for off-label use and medically accepted indications to support these expanded prescribing and administration powers.
LD 882 adds critical incident stress management peer support to the legal definition of "health care" in Maine law, protecting communications between these providers and people they assist. The bill designates peer support providers as mandatory reporters for suspected child abuse or neglect, requiring them to report such cases under state law. It establishes a legal privilege preventing these providers from being forced to testify about confidential communications during peer support sessions, except when a person's physical or mental condition is in question or a court deems disclosure necessary for justice. This protects the confidentiality of sensitive support conversations while ensuring child safety reporting obligations are met.
This joint resolution designates March 2026 as Social Work Month in Maine to honor the contributions of social workers to community well-being and social justice. The bill highlights how these professionals support vulnerable populations, advocate for civil rights, and improve access to mental health and educational services. It directs that copies of the resolution be sent to several state universities with social work programs and the Maine chapter of the National Association of Social Workers.
LD 858 creates a state grant program to help schools access behavioral and mental health services for students. It provides schools with $3,000 to $9,000 annually based on student population (e.g., $9,000 for schools over 500 students) to contract with licensed external providers. The grants cannot cover services already paid for by MaineCare, and funds must supplement - not replace - existing school mental health staff. This program, funded at $1.353 million yearly starting in 2025-26, directly supports school districts in expanding student mental health resources.
LD 163 requires all health insurance plans in Maine covering prescription drugs or outpatient services to fully cover federally approved nonprescription oral hormonal contraceptives and emergency contraceptives without any deductibles, copays, or coinsurance. This applies directly to health insurers and enrollees, eliminating out-of-pocket costs for these specific contraceptives. The bill clarifies that no prescription is needed to obtain these items, and coverage must include supplies for a full 12-month period. It specifically excludes coverage for abortion-inducing drugs. The law updates Maine’s health insurance coverage requirements to align with federal contraceptive approvals.
LD 93 expands Maine's Universal Childhood Immunization Program to cover all adults residing in the state, not just children under 19. The bill amends existing law to define "individual" as any Maine resident and modifies program administration to include adults in the vaccine coverage. It maintains the same funding mechanism through the Childhood Immunization Fund, requiring assessed entities (like insurance providers) to pay quarterly assessments based on the number of covered residents. This change aims to reduce costs and increase access to recommended vaccines for all age groups by extending the existing childhood program framework.
LD 380 amends Maine's Address Confidentiality Program to include gender-affirming health care practitioners as eligible participants, expanding the program beyond its prior focus on reproductive health care. This allows practitioners to use a designated address for mail and legal purposes, keeping their personal address confidential to enhance safety. The bill repeals prior provisions that had limited eligibility to reproductive health care practitioners and updates the program to cover both reproductive and gender-affirming services. The change is administrative and does not regulate the provision of health care services.
LD 1154 requires healthcare providers to inform women seeking an abortion for a fetus diagnosed with a lethal fetal anomaly (a condition likely to cause the baby's death within three months after birth) about perinatal hospice services as part of the informed consent process. Providers must discuss these services in person at least 24 hours before the procedure and provide a written list of available perinatal hospice providers, which the state will maintain. If the woman declines hospice services and chooses to proceed with the abortion, she must sign a written certification confirming her decision. This requirement does not apply in cases of medical emergencies or for abortions related to ectopic pregnancy or spontaneous miscarriage.
LD 1007 requires healthcare professionals in Maine to provide specific information during informed consent for drug-induced abortions. It mandates that providers inform patients about the potential for reversal if they change their mind (noting time sensitivity), and that initial studies suggest no increased maternal mortality or birth defect risks from reversal. Providers must also give patients a written statement with a website and helpline number (to be updated annually by the Department of Health) for information on abortion pill reversal services. This bill directly affects women seeking drug-induced abortions and their healthcare providers in Maine.
